May 2008 Articles

	2008 Annual Outsourcing Survey Gil Roth		Biopharma CMO Market Report Optimism is high among bio-contract manufacturers William Downey
	Paradigm Change in Bio-Manufacturing Technology is transforming manufacturing options Donald F. Gerson		Bio-Capacity in 2012 The outlook is bright for CMOs Eric S. Langer
	Thinking Inside the Box CMOs work to contain high potency biologics and APIs Cindy Dubin		Responding to a WARNING LETTER Part 2 of 2 on what to do when the FDA sends you a letter Shamik Pandit
	Complying with Track and Trace Biogen Idec blazes a path to California compliance Stephen Barlas

Contract Pharma Magazine: Click here to start your subscription to Contract Pharma Magazine

In Print:

Growth Opportunities & Strategies CAGR of 15% through 2014? By Barath Shankar	PAT and QbD for CMOs How will PAT alter the outsourcing equation? By Barry (Bir) Gujral, C. Freeman Stanfield and Doug Rufino
Preformulation: More of the Same An industry veteran explores the history of Preformulation By Frank Chrzanowski, Ph.D.	Pedigree Compliance Issues A best practice approach to collaboration in a pedigree world By Kim Loughead

Columns:

From the Editor
FDA Watch
Financial Analysis
Managing Your Career
The Lowe Down

Preclinical Outsourcing
Advanced Degrees
India Report
Bio News & Views
Ad Index